Solventum Corporation logo
Solventum Corporation (SOLV)
Compare

Solventum Corporation (SOLV) Average EV/EBITDA Ratio

EV/EBITDA Ratio

The current ev/ebitda ratio for Solventum Corporation (SOLV) is 6.69x as of Friday, June 12, 2026, shown against its trailing averages.

Average EV/EBITDA Ratio Chart

SOLV EV/EBITDA Ratio Averages

EV/EBITDA RATIO CURRENT

6.69x

EV/EBITDA RATIO TTM

10.17x

EV/EBITDA RATIO 3Y

10.29x

EV/EBITDA RATIO 5Y

10.29x

EV/EBITDA RATIO 10Y

10.29x

EV/EBITDA RATIO 15Y

10.29x

EV/EBITDA RATIO 20Y

10.29x

About Solventum Corporation

Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.

Maplewood, MN
22,000 employees
Healthcare / Medical - Care Facilities
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Bryan C. Hanson